Angelika Jahreis Selected Research

TNFR-Fc fusion protein (etanercept)

01/2008	Etanercept treatment for children and adolescents with plaque psoriasis.
06/2007	Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis.
03/2006	Patients with psoriasis respond to continuous open-label etanercept treatment after initial incomplete response in a randomized, placebo-controlled trial.
03/2006	Efficacy of etanercept in an integrated multistudy database of patients with psoriasis.
03/2006	Etanercept monotherapy in patients with psoriasis: a summary of safety, based on an integrated multistudy database.
01/2006	Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.
01/2006	Clinical response in psoriasis patients discontinued from and then reinitiated on etanercept therapy.
11/2005	Etanercept improves the health-related quality of life of patients with psoriasis: results of a phase III randomized clinical trial.

8	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2008 - 11/2005
1	Fatigue 01/2006
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2002

8	TNFR-Fc fusion protein (etanercept)FDA Link 01/2008 - 11/2005
1	CD40 Ligand (CD40L)IBA 03/2002